Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00237_DB00344_nanopub.RANgdqaxPVxxUs8u6-UEwSQz1TbWscBTkI9l2b7SqgrY0#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00237_DB00344 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00237_DB00344 label "DDI between Butabarbital and Protriptyline - Barbiturates like butabarbital may increase the metabolism of tricyclic antidepressants like protriptyline. Monitor for decreased therapeutic effects of tricyclic antidepressants if a barbiturate is initiated/dose increased, or increased effects if a barbiturate is discontinued/dose decreased. The tricyclic antidepressant dosage will likely need to be increased during concomitant barbiturate therapy, and reduced upon barbiturate discontinuation. [drugbank_resource:DB00237_DB00344]" assertion.
- drugbank_resource:DB00237_DB00344 identifier "drugbank_resource:DB00237_DB00344" assertion.
- drugbank_resource:DB00237_DB00344 title "DDI between Butabarbital and Protriptyline - Barbiturates like butabarbital may increase the metabolism of tricyclic antidepressants like protriptyline. Monitor for decreased therapeutic effects of tricyclic antidepressants if a barbiturate is initiated/dose increased, or increased effects if a barbiturate is discontinued/dose decreased. The tricyclic antidepressant dosage will likely need to be increased during concomitant barbiturate therapy, and reduced upon barbiturate discontinuation." assertion.
- drugbank:DB00237 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00237_DB00344 assertion.
- drugbank:DB00344 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00237_DB00344 assertion.